These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37013774)

  • 61. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract][Full Text] [Related]  

  • 62. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 63. METTL3-mediated m6A modification is required for cerebellar development.
    Wang CX; Cui GS; Liu X; Xu K; Wang M; Zhang XX; Jiang LY; Li A; Yang Y; Lai WY; Sun BF; Jiang GB; Wang HL; Tong WM; Li W; Wang XJ; Yang YG; Zhou Q
    PLoS Biol; 2018 Jun; 16(6):e2004880. PubMed ID: 29879109
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Critical Roles of METTL3 in Translation Regulation of Cancer.
    Meng W; Xiao H; Mei P; Chen J; Wang Y; Zhao R; Liao Y
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S; Jiang F; Chen F; Deng Y; Pan X
    J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic Hexavalent Chromium Exposure Upregulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-Like Property, and Tumorigenesis.
    Wang Z; Uddin MB; Xie J; Tao H; Zeidler-Erdely PC; Kondo K; Yang C
    Toxicol Sci; 2022 Apr; 187(1):51-61. PubMed ID: 35201342
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 69. METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m
    Kim Y; Shin S; Kwon S; Moon K; Baek SV; Jo A; Kim HS; Hwang GH; Bae S; Kim YH; Cho SY; Oh JM
    Am J Cancer Res; 2023; 13(4):1443-1456. PubMed ID: 37168328
    [TBL] [Abstract][Full Text] [Related]  

  • 70. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
    Sun Y; Shen W; Hu S; Lyu Q; Wang Q; Wei T; Zhu W; Zhang J
    J Exp Clin Cancer Res; 2023 Mar; 42(1):65. PubMed ID: 36932427
    [TBL] [Abstract][Full Text] [Related]  

  • 71. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
    Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
    Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y
    Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer.
    Li Y; Zhang X; Cai J; Ren L; Liu B; Wu M; Lu W; Li R; Zhang C; Huang C; Tong J; Liu A; Zheng Y; Ren D; Guo Y; Huang Y
    J Gene Med; 2022 Feb; 24(2):e3397. PubMed ID: 34751492
    [TBL] [Abstract][Full Text] [Related]  

  • 75. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 76. METTL3-mediated m6A modification promotes processing and maturation of
    Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
    Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer's Disease.
    Huang H; Camats-Perna J; Medeiros R; Anggono V; Widagdo J
    eNeuro; 2020; 7(5):. PubMed ID: 32847866
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis.
    Chen S; Su X; Wang J; Zheng N; Tang Y; Peng G; Dong R; Lu F; Liu M; Zhao Y; Wu H
    Front Oncol; 2022; 12():935239. PubMed ID: 35965524
    [TBL] [Abstract][Full Text] [Related]  

  • 79. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.
    Ouyang D; Hong T; Fu M; Li Y; Zeng L; Chen Q; He H; Wen Y; Cheng Y; Zhou M; Zou Q; Yi W
    Breast Cancer Res; 2023 Feb; 25(1):19. PubMed ID: 36765397
    [TBL] [Abstract][Full Text] [Related]  

  • 80. METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.
    Zhang C; Chen L; Peng D; Jiang A; He Y; Zeng Y; Xie C; Zhou H; Luo X; Liu H; Chen L; Ren J; Wang W; Zhao Y
    Mol Cell; 2020 Aug; 79(3):425-442.e7. PubMed ID: 32615088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.